deferoxamine has been researched along with fg-4592 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cordes, BA; Iempridee, T; Kraus, RJ; Lambert, PF; Lee, DL; Mertz, JE; Patel, P; Sathiamoorthi, S; Yu, X; Yuan, X | 1 |
1 other study(ies) available for deferoxamine and fg-4592
Article | Year |
---|---|
Reactivation of Epstein-Barr Virus by HIF-1α Requires p53.
Topics: Cell Line, Tumor; Cyclopentanes; Deferoxamine; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Glycine; Herpesvirus 4, Human; Host-Pathogen Interactions; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Iron Chelating Agents; Isoquinolines; Lymphocytes; Morpholines; Piperazines; Prolyl-Hydroxylase Inhibitors; Promoter Regions, Genetic; Protein Binding; Pyrimidines; Pyrones; Response Elements; RNA, Small Interfering; Signal Transduction; Trans-Activators; Tumor Suppressor Protein p53; Virus Activation | 2020 |